To confirm the on-target effect of KIF20A sgRNAs on BCSC initiation in vivo, we carried out tumor initiating assay with limiting dilutions by re-expressing sgRNA-resistant KIF20A in KIF20A-depleted cells (sg1). This evidence concerns the gene KIF20A and neoplasm.